Latest episodes of the podcast VJHemOnc Podcast
Mostrando página 3 de 10
Post-ASH non-malignant highlights: updates in sickle cell disease, thalassemia, and hemophilia
14/02/2025
Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025
06/02/2025
Post-ASH MDS highlights: managing anemia in LR-MDS and novel approaches to treating HR-MDS
17/01/2025
The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS
06/11/2024
Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events
01/11/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.